NeuroSense Therapeutics Ltd - Warrants (09/11/2026) PEG Ratio

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW) currently reports a PEG ratio of -1.21. That is below the sector sector average of 6.6. Use the charts on this page to explore NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s PEG ratio history and peer comparisons.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s PEG ratio of -1.21 is lower than the its sector sector average of 6.6. That is roughly 118.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s market price to a fundamental measure such as earnings, sales, or book value. At -1.21, NRSNW can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -1.21, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 6.6. From there, open related valuation or income-statement pages for NeuroSense Therapeutics Ltd - Warrants (09/11/2026), and consider following NRSNW for alerts when major investors trade the stock.